Research Activity – Talk Bio

Actionable Insights Powered by AI

JPM26: Pfizer Fast-Tracks Obesity Programs in Race Against Patent Cliff

3 days ago talkbio0Tagged JPM26, Metsera, Obesity drugs, Patent Cliff, Pfizer, Phase 3 Clinical Trials

Pfizer; Obesity Drugs; Metsera; Phase III Trials; Albert Bourla; JPM26; Patent Cliff

Eli Lilly and Nvidia Announce $1 Billion, Five-Year AI Co-Innovation Lab Partnership in Bay Area

3 days ago talkbio0Tagged AI lab, Bay Area, Drug Discovery, eli lilly, JPM, NVIDIA

Eli Lilly; Nvidia; AI lab; drug discovery; $1 billion; Bay Area; JPM 2026

Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs

3 days ago talkbio0Tagged annamycin, Clinical Trials, Leukemia, Myelocytic, Acute, milestones, MIRACLE trial, Moleculin, WP1066

Moleculin; MIRACLE trial; Annamycin; WP1066; AML; clinical trials; 2026 milestones

Dr Melanie Ivarsson Appointed CEO of Health Data Research Service

3 days ago talkbio0Tagged Appointments, Barakat syndrome, CEO, health data, Health Data Research Service, Medical Research activity, Melanie Ivarsson, UK

Dr Melanie Ivarsson; Health Data Research Service; HDRS; CEO appointment; UK health data; medical research

Insilico Medicine and Servier Announce Up to $888 Million AI-Driven Oncology R&D Collaboration

2 weeks ago talkbio0Tagged AI Platform, Drug Discovery, Insilico Medicine, Neoplasms, Pharma, Servier

Insilico Medicine; Servier; AI platform; oncology; drug discovery; Pharma.AI; $888 million

Genelux Corporation Appoints Jason Litten, M.D., as Chief Medical Officer to Advance Olvi-Vec Development

2 weeks ago talkbio0Tagged Chief Medical Officer, Chronic multifocal osteomyelitis, Clinical Trials, Genelux Corporation, immuno-oncology, Jason Litten

Genelux Corporation; Jason Litten; Chief Medical Officer; CMO; Olvi-Vec; immuno-oncology; clinical trials

Insilico Medicine Caps 2025 with Record HKD 2.277 Billion Hong Kong IPO

2 weeks ago talkbio0Tagged AI biotech, Drug Discovery, HKEX, Hong Kong IPO, Insilico Medicine

Insilico Medicine; Hong Kong IPO; AI biotech; HKEX listing; drug discovery

Patient Dies from Thrombotic Stroke in Pfizer’s Hympavzi Hemophilia Trial After Minor Surgery

3 weeks ago talkbio0Tagged Clinical Trials, Hemophilia A, HYMPAVZI, marstacimab, Patient Death, Pfizer, Thrombotic Stroke

Pfizer; Hympavzi; marstacimab; hemophilia; thrombotic stroke; patient death; clinical trial

FDA places partial clinical hold on Merck and Daiichi Sankyo’s I-DXd lung cancer trial after interstitial lung disease deaths

4 weeks ago talkbio0Tagged Antibody-Drug Conjugates, Clinical Trials, Daiichi, Deruxtecan, grade 5 ILD, I-DXd, IDeate-Lung02, ifinatamab, Lung Diseases, Interstitial, Merck, Partial, Sankyo, Small cell carcinoma of lung, United States Food and Drug Administration

FDA partial clinical hold; ifinatamab deruxtecan; I-DXd; IDeate-Lung02; Merck; Daiichi Sankyo; small cell lung cancer; interstitial lung disease; grade 5 ILD; antibody-drug conjugate; clinical trial deaths

Moderna Lands CEPI as New Backer for Its Pandemic Flu (H5 Bird Flu) Program

4 weeks ago talkbio0Tagged CEPI, coalition, Epidemic Preparedness Innovations, Funding, H5 bird flu, Moderna, mRNA Vaccine, pandemic influenza, pandemic preparedness, Phase 3 trial, Vaccine Development

Moderna; CEPI; Coalition for Epidemic Preparedness Innovations; pandemic influenza; H5 bird flu; mRNA vaccine; Phase 3 trial; pandemic preparedness; vaccine development; funding